Resiquimod

Resiquimod
Clinical data

Routes of administration	Topical
ATC code	none
Legal status
Legal status	Investigational
Identifiers
IUPAC name 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol
CAS Number	144875-48-9^Y
PubChem CID	159603
IUPHAR/BPS	5051
ChemSpider	140330^N
UNII	V3DMU7PVXF
ChEMBL	CHEMBL383322^N
Chemical and physical data
Formula	C₁₇H₂₂N₄O₂
Molar mass	314.382 g/mol
3D model (Jmol)	Interactive image
SMILES CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N
InChI InChI=1S/C17H22N4O2/c1-4-23-9-13-20-14-15(21(13)10-17(2,3)22)11-7-5-6-8-12(11)19-16(14)18/h5-8,22H,4,9-10H2,1-3H3,(H2,18,19)^N Key:BXNMTOQRYBFHNZ-UHFFFAOYSA-N^N
^NY (what is this?)

Resiquimod (R-848) is a drug that acts as an immune response modifier, and has antiviral and antitumour activity. It is used as a topical gel in the treatment of skin lesions such as those caused by the herpes simplex virus and cutaneous T cell lymphoma, and as an adjuvant to increase the effectiveness of vaccines. It has several mechanisms of action, being both an agonist for toll-like receptor 7 and 8, and an upregulator of the opioid growth factor receptor.